Revolutionizing MRI Scanning: AIRS Medical's SwiftMR® Gains FDA Approval for Deep Learning Enhancements
AIRS Medical's SwiftMR® Receives FDA Clearance
In a major development for medical imaging, AIRS Medical announced that its innovative MRI image enhancement platform, SwiftMR®, has obtained FDA 510(k) clearance for integration with original equipment manufacturers' (OEM) deep learning reconstruction solutions. This milestone offers a new avenue for healthcare providers looking to optimize their imaging workflows.
Enhancing Imaging Capabilities
SwiftMR not only complements existing OEM deep learning (DL) solutions but also extends their functionality. For facilities already equipped with OEM DL systems, the integration of SwiftMR can provide significant benefits. For instance, at an imaging center utilizing a GE 3T scanner with AIR Recon DL, scans that typically take 15 minutes were reduced to just 9 minutes, demonstrating a remarkable enhancement in efficiency.
Conversely, in instances where OEM DL solutions are not equipped to handle certain scan sequences, SwiftMR fills the gap. It provides comprehensive coverage for all pulse sequences across various body parts, thereby utilizing AI-driven enhancements to reduce both scan time and improve image quality. Since receiving FDA clearance, SwiftMR has been deployed in clinical settings, driving efficiency improvements since its development in 2023.
The Impact on Imaging Schedules
Jina Park, AIRS Medical's Chief Strategy Officer, explained that the difference in scan duration could significantly affect the scheduling of appointments. The ability to reduce the scan time from 15 minutes to 10 could allow facilities to transition from 30-minute slots to 20-minute slots. This not only maximizes the use of equipment but also helps facilities serve more patients effectively.
Guaranteed Quality and Performance
As per statements from Woojin Jung, the Head of Product at AIRS Medical, the technology behind SwiftMR was specifically tailored and tested on images processed by various OEM DL technologies. The recent FDA clearance assures customers of its quality, encouraging its adoption in medical imaging centers nationwide.
Availability and Future Prospects
With the FDA’s nod, SwiftMR is now available for imaging centers and hospitals that aim to achieve quicker scan times and reduce patient appointment durations. Medical facilities interested in experiencing the capabilities of SwiftMR can request demos via the official AIRS Medical website, airsmed.com.
About AIRS Medical
AIRS Medical is at the forefront of AI-driven advancements in medical imaging, with its solutions, including SwiftMR and SwiftSight, utilized globally at advanced health systems. These innovations mark a significant step forward in transforming MRI technology, making patient care more efficient and less time-consuming.
To learn more about these advancements or to request a demo, visit airsmed.com.
For detailed specifications and performance data, additional information can be found on their website. The clinical results, including those reducing scan time, may vary based on specific scanner configurations and imaging protocols. Therefore, it's important for healthcare providers to assess the applicability of SwiftMR based on their unique settings and patient needs.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.